Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
2023 · New England Journal of Medicine · 336 citations
https://doi.org/10.1056/nejmoa2309169
R
Renaud Sabatier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
239
Papers
4.7K
Citations
32
h-index
74
i10-index
Renaud Sabatier is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 32, co-authored 204 publications.
ORCID: 0000-0002-5821-682XPapers by this author
worksSwitch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
2022 · The Lancet Oncology · 291 citations
https://doi.org/10.1016/s1470-2045(22)00555-1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
2022 · The Lancet Oncology · 291 citations
https://doi.org/10.1016/s1470-2045(22)00555-1
A gene expression signature identifies two prognostic subgroups of basal breast cancer
2010 · Breast Cancer Research and Treatment · 285 citations
https://doi.org/10.1007/s10549-010-0897-9
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
2014 · Molecular Cancer · 131 citations
https://doi.org/10.1186/1476-4598-13-228
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
2017 · European Journal of Cancer · 59 citations
https://doi.org/10.1016/j.ejca.2017.08.025
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat